Fujifilm's Avigan shown to be effective in Japanese Phase-3 trial for COVID-19

Fujifilm Holdings Corp said on Wednesday a late-stage study of its antiviral drug Avigan showed it reduced recovery times for COVID-19 patients with non-severe symptoms, boosting expectations for regulatory approval in Japan.

from bdnews24.com - Home https://ift.tt/32V3w6p